A recent three-year study concluded that Pivot Bio’s microbial products effectively deliver nitrogen while delivering greater ROI to the grower. Precision Technology Institute recently published ...
Korro Bio (KRRO) announced the initiation of dosing in its REWRITE study investigating KRRO-110 as a potential treatment for individuals with ...
Annovis Bio (ANVS) announced that the FDA has accepted an updated protocol for the pivotal Phase 3 Alzheimer’s Disease study, which is slated to begin in January 2025. In October 2024 ...
Chief Medical Officer and Head of Development at Zura Bio. “The initiation of the TibuSURE study marks a significant milestone in addressing certain urgent, unmet needs of this patient ...
SAN DIEGO--(BUSINESS WIRE)--Opna Bio, a clinical-stage biopharmaceutical ... is being evaluated in an ongoing Phase 1 investigator-led study in patients with advanced myelofibrosis who are no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results